Melior Pharmaceuticals Announces Execution of License Agreement
29 Jul 2021 //
BUSINESSWIRE
Melior has signed a “letter of intent” with Adhera Therapeutics
07 Jun 2021 //
BUSINESSWIRE
Melior Pharmaceuticals to initiate trial of Covid-19 drug
10 Mar 2021 //
CLINICALTRIALSARENA
Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
09 Mar 2021 //
BUSINESSWIRE
Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
09 Mar 2021 //
BUSINESSWIRE